Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine and Treatment Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the Infectious Diseases Clinical Research Consortium, hereafter referred to as the Leadership Group (LG), which provides for overall administrative and scientific leadership for the clinical research and clinical trials conducted. While the primary scientific focus will be on product evaluation for NIAID priority areas, including malaria/neglected tropical diseases, sexually transmitted infections, respiratory infections, and enteric diseases, the VTEUs must also provide surge capacity to address emerging infectious diseases
[Global Fund] The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomes the Japanese Diet's passage of the fiscal 2019 supplementary budget and the fiscal 2020 budget, which includes Japan's contribution of US$476.4 million to the Global Fund in 2020. This is its largest annual contribution to the Global Fund, signaling Japan's strong leadership in global health, at a time when the world is fighting COVID-19.
[Thomson Reuters Foundation] London -Diseases like tuberculosis and malaria largely ravage low-income countries, with the situation made worse by poor nutrition and sanitation
[New Zimbabwe] THE Global Fund has announced that it has allocated US$500 million to Zimbabwe to fight against malaria, HIV and coronavirus.
[allAfrica] Cape Town -AllAfrica's Juanita Williams talked with Mark Suzman, the CEO of the Bill and Melinda Gates Foundation, the world's largest philanthropy. He assumed the position this month. In this second part of the interview, he discussed how his early career as a journalist in his native South Africa influences his perspectives; about the possibilities of eliminating malaria and reducing HIV, TB and other diseases; addressing hunger and undernutrition amid the climate crisis; and the biggest challenges he faces. Part 2
[Daily News] MANY developing countries have been struggling to control malaria, HIV, and maternal mortality, but for Zanzibar the progress is arguably encouraging.
[Nation] The Global Fund -- the agency that helps Kenya fight HIV/Aids, tuberculosis and malaria -- has given the country Sh42 billion to be used up to 2024.
[FrontPageAfrica] Bomi County -The Liberia Coordinating Mechanism (LCM) of the Global Fund (TGF) to fight AIDS, TB and Malaria has commenced a regional consultative prioritization country dialogue to develop a joint funding request for Tuberculosis and HIV, on behalf of the country, for submission to the Fund.
[The Herald] Zimbabwe is assured of an adequate supply of anti-retroviral drugs (ARVs) following the allocation of US$500 million for the next three years by the Global Fund to Fight Aids, Tuberculosis and Malaria.
[Global Fund] Geneva -Following a record-breaking Replenishment in October 2019, the Global Fund today announced its largest-ever funding allocations for eligible countries to fight AIDS, tuberculosis and malaria and build systems for health over the next three years.
[The Conversation Africa] The infectious disease burden in Africa is very high, particularly for tuberculosis (TB), malaria and HIV/AIDS. In 2018, nearly a quarter (24%) of TB cases in the world were in Africa. The region accounted for 93% of malaria cases. The continent also bears the brunt of the HIV epidemic: 20.6 million of the 37.9 million people living with HIV are in eastern and southern Africa.